Skip 
Navigation Link

1215 South Walnut Ave.
Demopolis, AL 36732 map map 

Access to Care: 334.289.2410

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Opioid Rxs Decreasing, But Not for All DoctorsAfter Chinese Infant Gene-Editing Scandal, U.S. Health Officials Join Call for a BanAre 'Inactive' Ingredients in Your Drugs Really So Harmless?Need to Be Vaccinated? Try Your Local PharmacyBystanders Key to Cutting Cardiac Arrest DeathsMany Black Americans Live in Trauma Care 'Deserts'FDA Issues Asbestos Warning About Some Claire's Cosmetic ProductsFDA to Crack Down on Retailers That Keep Selling Tobacco to KidsBlood Donation by Teen Girls May Raise Anemia RiskNurses' Long Hours, Moonlighting Could Pose Patient Safety RiskBerkeley's Efforts Suggest Soda Taxes Do Cut Soda SalesOpioid Overdose Deaths Quadruple, Centered in 8 StatesPayments for Research Can Lead to Lies: StudyFDA Aims to Strengthen Sunscreen RulesAre Primary Care Doctors Prepared to Discuss Cancer Treatment?FDA Fell Short in Preventing Fentanyl Abuse Crisis, Report ClaimsPrimary Care Doctors Help Boost Life Spans, But More Are NeededMore Car Crashes Tied to Drivers High on OpioidsPoor Whites Bear the Brunt of U.S. Opioid Crisis, Studies FindFDA to Tighten Oversight of SupplementsAs U.S. Measles Outbreaks Spread, Why Does 'Anti-Vax' Movement Persist?Even Brief EMS Delay Can Cost Lives After Car CrashHealth Tip: Know Your Family's Medical HistoryPatients With Primary Care Docs May Get Better Health CareBlood Donors Needed as Cold Weather Freezes U.S. SupplyAHA: Medical Experts 'Sound the Alarm' on Medical MisinformationWhite House Plan to Disclose Drug Prices May Not Drive Down Costs: StudyCan Artificial Intelligence Read X-Rays?Virtual Doctor Visits Get High Marks in New SurveyBig Pharma's Marketing to Docs Helped Trigger Opioid Crisis: StudyDisrupted Sleep Plagues Hospital Patients, But New Program Might HelpOpioid Prescriptions Almost Twice as Likely for Rural vs. Urban AmericansClimate Change Already Hurting Human Health, Review ShowsCalling All Blood Donors …Even Older Drugs Are Getting Steep Price Hikes, Study FindsAs Medical Marketing Soars, Is Regulation Needed?Radiation Doses From CT Scans Vary WidelyU.S. Leads Health Care Spending Among Richer Nations, But Gets LessIs Your State a Hotspot for Obesity-Linked Cancers?Health Tip: Choose the Right DoctorFDA Warns Companies on Dangerous, Unapproved Stem Cell TreatmentsMore U.S. Kids Dying From Guns, Car AccidentsRoad Rules on Smartphone Use Are Saving Bikers' Lives, TooAHA: Should Pacemakers, Defibrillators Be Recycled -- and Reused in Others?California Farm Tied to E. coli Outbreak Expands Recall Beyond Romaine LettuceHealth Tip: Use Medical Devices SafelyCalifornia Farm Implicated in Outbreak of E. coli Tied to Romaine LettuceFentanyl Now the No. 1 Opioid OD KillerHospitalizations Rising Among the HomelessElectronic Health Records Bogging Docs Down
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

FDA Issues Asbestos Warning About Some Claire's Cosmetic Products

HealthDay News
by -- Robert Preidt
Updated: Mar 6th 2019

new article illustration

WEDNESDAY, March 6, 2019 (HealthDay News) -- Consumers should avoid certain Claire's cosmetic products that may contain potentially cancer-causing asbestos because the company has refused to recall the items, the U.S. Food and Drug Administration warned Tuesday.

The agency's concern dates back two years, when the FDA first became aware of reports of possible asbestos contamination in some cosmetic products sold by Claire's and Justice retailers. Those initial tests were conducted by third-party laboratories, so the FDA ordered further tests by an independent lab.

In a statement, the agency said that further testing confirmed the presence of asbestos in samples of three cosmetic products from Claire's and one product sample from Justice. The Justice product has been recalled by the company, but Claire's has refused to recall the three products that tested positive for asbestos.

Those products are: Claire's Eye Shadows, Batch No/Lot No: 08/17; Claire's Compact Powder, Batch No/Lot No: 07/15; and Claire's Contour Palette, Batch No/Lot No: 04/17.

The FDA said it doesn't have the authority to force Claire's to recall the products, which is why it is warning consumers not to use them. The agency also said that consumers and health care providers should report any cosmetic-related problems to the FDA's MedWatch reporting system.

Cosmetics are not required to be approved by the FDA, the agency noted. However, it does have some tools to protect consumers.

For example: "Cosmetics must not be 'adulterated' or 'misbranded,' meaning they must be safe for consumers when used according to directions on the label, or in the customary or expected way, and they must be properly labeled," explained FDA Commissioner Dr. Scott Gottlieb.

The FDA also announced new measures, including "working with cosmetics manufacturers and requesting information about what procedures they use to ensure their cosmetics are safe." Specifically, the agency said it will ask manufacturers how "they ensure that talc used in any cosmetic product is free from asbestos."

The FDA stressed that the vast majority of cosmetics that contain talc are not thought to contain asbestos.

"In 2010, we surveyed 34 cosmetic products including body powders, face powders, foundation, eye shadow, blush and samples from four major talc suppliers and found no traces of asbestos contamination using the most sensitive techniques available," Gottlieb noted.

But stepped-up inquiries with cosmetics maker should "help us better identify specific cosmetic products and raw ingredient suppliers that may be more likely to be contaminated," he added.

The FDA is also asking cosmetics companies to register their products and list ingredients, including talc, used in their products.

More information

The U.S. Food and Drug Administration has more on talc.